Publications by authors named "Michael Toboni"

Claim this Profile
C
Circulating tumor DNA monitoring in ovarian cancer patients receiving PARPi maintenance therapy: Can we further personalize treatment?
Michael D Toboni, Elizabeth T Evans, Carly Bess Scalise, Melissa Hardesty, Tara Berman

Gynecol Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
AXL inhibition improves the therapeutic efficacy of trastuzumab in high-risk endometrial cancer.
Jo'an Tankou, Sofia Ruau, Anjali Walia, Michael Toboni, Hollie Noia

Gynecol Oncol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The use of transrectal ultrasound to improve gynecologic interstitial applicator implantation.
Katelyn Ragland, Joel Pogue, Eric Simiele, Samantha Simiele, Michael Soike, Michael D Toboni

Gynecol Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Age-specific incidence and five-year relative survival of endometrial cancer histotypes by race and ethnicity among US women, 2000 to 2019.
Megan A Clarke, Nicolas Wentzensen, Martin Köbel, Britt K Erickson, Akemi T Wijayabahu, Michael D Toboni

Gynecol Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Using Circulating Tumor DNA-Based Molecular Residual Disease Detection for Postoperative Monitoring in Early-Stage Uterine Cancer.
Peter W Ketch, Carly Bess Scalise, Fernando Recio, Tara Berman, Nicole Hook, Michael D Toboni

JCO Precis Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Venous thromboembolism risk for patients with BMI ≥40 kg/m undergoing robotic surgery for endometrial cancer.
Kaitlyn G Dinkins, Grace M Lee, Peter W Ketch, Michael D Toboni, Charles A Leath

Gynecol Oncol Rep· June 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Updates and controversies in the management of uterine serous carcinoma and uterine carcinosarcoma.
Michael Toboni, Katherine Kurnit, Britt Erickson, Matthew Powell, Angeles Alvarez Secord

Int J Gynecol Cancer· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trends in FDA approvals of gynecologic oncology therapeutics from 2019 to 2024.
Kaitlyn G Dinkins, Grace M Lee, Rebecca C Arend, Charles A Leath, Michael D Toboni

Gynecol Oncol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Not all uterine carcinosarcomas are created equal: Survival outcomes according to molecular characterization of uterine carcinosarcoma.
Michael D Toboni, Kaitlyn Dinkins, Sharon Wu, Tyler Mattox, Matthew J Oberley

Gynecol Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Characterizing the genomic landscape through the lens of FOLR1 status in low and high grade serous ovarian carcinoma.
Tullia Rushton, Harris B Krause, Timothy Samec, Andrew Elliott, Anthony N Karnezis, Michael D Toboni

Gynecol Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential Responses to Immune Checkpoint Inhibitors are Governed by Diverse Mismatch Repair Gene Alterations.
Moh'd M Khushman, Michael D Toboni, Joanne Xiu, Upender Manne, Alex Farrell

Clin Cancer Res· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Management of a complete mole and coexisting fetus in post-dobbs world.
Jordan Barton Garcia, Angela R Seasely, Damien Roland, Hua Guo, Margaret Boozer, Michael D Toboni

Gynecol Oncol Rep· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Differential outcomes and immune checkpoint inhibitor response among endometrial cancer patients with MLH1 hypermethylation versus MLH1 "Lynch-like" mismatch repair gene mutation.
Michael D Toboni, Sharon Wu, Alex Farrell, Joanne Xiu, Jennifer R Ribeiro

Gynecol Oncol· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sociodemographic characteristics and cervical cancer survival in different regions of the United States: a National Cancer Database study.
Michael D Toboni, Alexander Cohen, Zachary L Gentry, Stuart A Ostby, Zhixin Wang

Int J Gynecol Cancer· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
GAS6/AXL Inhibition Enhances Ovarian Cancer Sensitivity to Chemotherapy and PARP Inhibition through Increased DNA Damage and Enhanced Replication Stress.
Mary M Mullen, Elena Lomonosova, Michael D Toboni, Alyssa Oplt, Emily Cybulla

Mol Cancer Res· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New Treatments for Recurrent Uterine Cancer.
Michael D Toboni, Matthew A Powell

Curr Oncol Rep· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of AXL and VEGF-A Has Improved Therapeutic Efficacy in Uterine Serous Cancer.
Michael D Toboni, Elena Lomonosova, Shaina F Bruce, Jo'an I Tankou, Mary M Mullen

Cancers (Basel)· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Uterine carcinosarcomas: From pathology to practice.
Michael D Toboni, Erin K Crane, Jubilee Brown, Alexander Shushkevich, Sarah Chiang

Gynecol Oncol· July 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
State of the science: Uterine sarcomas: From pathology to practice.
Alexander Shushkevich, Premal H Thaker, Ramey D Littell, Naishadh A Shah, Sarah Chiang, Michael D Toboni

Gynecol Oncol· October 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reducing emergency department (ED) computed tomography (CT) utilization in women treated for gynecologic cancers.
Stuart A Ostby, Joel G Evans, Haller J Smith, Teresa K L Boitano, Michael D Toboni

Gynecol Oncol· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systemic Treatment of Metastatic/Recurrent Uterine Leiomyosarcoma: A Changing Paradigm.
Rebecca C Arend, Michael D Toboni, Allison M Montgomery, Robert A Burger, Alexander B Olawaiye

Oncologist· December 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Vulvar Cancer as a Result of GATA2 Deficiency, a Rare Genetic Immunodeficiency Syndrome.
Michael D Toboni, Kerri S Bevis

Obstet Gynecol· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of Unplanned Reoperation for Ovarian Cancer Patients From the National Surgical Quality Improvement Program Database.
Michael D Toboni, Haller J Smith, Sejong Bae, J Michael Straughn, Charles A Leath

Int J Gynecol Cancer· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Malignant Brenner tumor associated with a germline mutation.
Michael D Toboni, Haller J Smith, Sarah E Dilley, Lea Novak, Charles A Leath

Gynecol Oncol Rep· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Contributing factors for menopausal symptoms after surgical staging for endometrial cancer.
Koji Matsuo, Marc R Gualtieri, Sigita S Cahoon, Michael D Toboni, Hiroko Machida

Menopause· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis